Qsemble Capital Management LP Makes New $1.32 Million Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Qsemble Capital Management LP bought a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 17,482 shares of the company's stock, valued at approximately $1,324,000.

Several other large investors also recently modified their holdings of the company. JPMorgan Chase & Co. increased its position in Henry Schein by 1.1% in the third quarter. JPMorgan Chase & Co. now owns 4,766,305 shares of the company's stock worth $353,898,000 after purchasing an additional 53,506 shares during the last quarter. American Century Companies Inc. lifted its position in Henry Schein by 7.3% during the third quarter. American Century Companies Inc. now owns 4,719,088 shares of the company's stock valued at $350,392,000 after acquiring an additional 322,649 shares during the last quarter. Northern Trust Corp lifted its position in Henry Schein by 2.8% during the third quarter. Northern Trust Corp now owns 1,647,889 shares of the company's stock valued at $122,356,000 after acquiring an additional 45,561 shares during the last quarter. Lazard Asset Management LLC raised its holdings in shares of Henry Schein by 1,303.3% in the third quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company's stock worth $92,614,000 after buying an additional 1,158,451 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Henry Schein by 2.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,137,623 shares of the company's stock worth $86,129,000 after acquiring an additional 29,683 shares during the period. Institutional investors own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on HSIC. Leerink Partnrs reissued a "market perform" rating on shares of Henry Schein in a research note on Monday, February 26th. TheStreet upgraded shares of Henry Schein from a "c+" rating to a "b-" rating in a research report on Monday, February 26th. JPMorgan Chase & Co. raised their target price on shares of Henry Schein from $82.00 to $88.00 and gave the company an "overweight" rating in a report on Wednesday, March 6th. Jefferies Financial Group boosted their target price on shares of Henry Schein from $74.00 to $81.00 and gave the stock a "hold" rating in a research report on Wednesday, March 6th. Finally, Piper Sandler lifted their price target on shares of Henry Schein from $78.00 to $86.00 and gave the stock an "overweight" rating in a research note on Monday, February 26th. One analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $81.73.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the business's stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares of the company's stock, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the company's stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares of the company's stock, valued at approximately $5,430,462.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Henry Schein Stock Performance

Shares of HSIC traded down $0.13 during mid-day trading on Friday, hitting $73.31. The company's stock had a trading volume of 850,463 shares, compared to its average volume of 1,078,406. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.75. The firm has a market capitalization of $9.42 billion, a PE ratio of 24.77, a price-to-earnings-growth ratio of 1.92 and a beta of 0.87. The stock's 50-day moving average is $72.88 and its two-hundred day moving average is $72.43.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.21 billion. During the same period in the prior year, the company posted $1.21 earnings per share. The business's revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 5.08 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.